Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Adam Saltzman

Advanced Heart Failure and Transplant Cardiology Fall River, MA Medical Doctor

NPI 1346452737 CMS profile 61218

363 Highland Ave, Fall River, MA 02720

Open in the dashboard

General payments

$68,271

138 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$180,599 paid to institutions, not to them · program years 2019–2025

Through program year 2025, Adam Saltzman of Fall River, MA is reported in the CMS Open Payments database as having received $68,271 across 138 general payments and $0 in research payments paid to them. Separately, studies naming them as principal investigator received $180,599 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 82nd percentile of Advanced Heart Failure and Transplant Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $4,525 25
2024 General $155 3
2023 General $22,819 20
2022 General $17,137 25
2021 General $6,863 33
2020 General $11,089 16
2019 General $5,681 16

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Adam Saltzman
  • Advanced Heart Failure and Transplant Cardiology median
  • Middle half of Advanced Heart Failure and Transplant Cardiology
  • National median

In program year 2025, general payments to Adam Saltzman were reported at $4,525. Among 967 Advanced Heart Failure and Transplant Cardiology profiles paid that year, the median was $1,024 and the middle half received between $289 and $6,890.

Show as a table
Year Adam Saltzman Advanced Heart Failure and Transplant Cardiology median Middle half National median
2019 $5,681 $863 $224–$4,562 $163
2020 $11,089 $452 $122–$3,992 $114
2021 $6,863 $550 $159–$3,571 $132
2022 $17,137 $729 $221–$4,357 $149
2023 $22,819 $1,002 $309–$5,827 $160
2024 $155 $931 $273–$5,204 $164
2025 $4,525 $1,024 $289–$6,890 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Edwards Lifesciences Corporation $42,780 87 payments
  2. Boston Scientific Corporation $19,637 17 payments
  3. Abbott Laboratories $5,253 23 payments
  4. Medtronic, Inc. $309 5 payments
  5. Abiomed $103 2 payments
  6. Medacta USA, Inc. $100 1 payment
  7. Shockwave Medical, Inc $46 2 payments
  8. Medtronic Vascular, Inc. $43 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $36,988 11 payments
  2. Travel and Lodging $12,898 38 payments
  3. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $9,000 2 payments
  4. Food and Beverage $5,885 85 payments
  5. Compensation for serving as faculty or as a speaker for a non-accredited and noncertified continuing education program $2,000 1 payment
  6. Honoraria $1,500 1 payment
Products named General payments · program years 2019–2025
  1. EDWARDS SAPIEN 3 TRANSCATHETER HEART VALVE (THV) $29,131 58 payments
  2. Edwards SAPIEN 3 Ultra Transcatheter Heart Valve $9,697 6 payments
  3. WATCHMAN $9,109 3 payments
  4. Mitra Clip system $3,638 7 payments
  5. Edwards SAPIEN 3 Transcatheter Heart Valve $3,523 14 payments
  6. GENERAL THERAPIES $2,400 1 payment
  7. TRICLIP $1,409 12 payments
  8. GENERAL - STENTS $168 2 payments
  9. COREVALVE EVOLUT R $134 2 payments
  10. WATCHMAN FLX $118 2 payments
  11. Other $781 14 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 53 billing codes

Paid by Medicare

$195,660

Medicare's payments for the services billed

Medicare patients

417

Average age 78

Services billed

1,676

189 women, 228 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 73%
Heart failure 72%
Arthritis 55%
Atrial fibrillation 53%
Chronic kidney disease 47%
Diabetes 43%
COPD 33%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

138 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Advanced Heart Failure and Transplant Cardiology in Massachusetts

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record